Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facts and Hopes in Immunotherapy of Pancreatic Cancer
Bruno Bockorny, Joseph E. Grossman, Manuel Hidalgo
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4606-4617
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R. Ferrone, Matthew H. G. Katz, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 5, pp. 318-337
Closed Access | Times Cited: 211
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis
Weimin Hu, Si-Qing Liu, Kongfan Zhu, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110505-110505
Closed Access | Times Cited: 26
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia
Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Swati Swagatika Swain, et al.
Cancer Letters (2024) Vol. 588, pp. 216782-216782
Open Access | Times Cited: 10
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells
Chunbo He, Dezhen Wang, Surendra K. Shukla, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 176-193
Open Access | Times Cited: 19
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
Kwangsoo Kim, Karl J. Habashy, Andrew Gould, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 2044-2060
Closed Access | Times Cited: 7
Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review
Yutaka Endo, Minoru Kitago, Yuko Kitagawa
Cancers (2024) Vol. 16, Iss. 9, pp. 1632-1632
Open Access | Times Cited: 5
Mistletoe extract in patients with advanced pancreatic cancer: a double-blind, randomized, placebo-controlled trial (MISTRAL)
Kathrin Wode, Gunver S. Kienle, Ove Björ, et al.
Deutsches Ärzteblatt international (2024)
Open Access | Times Cited: 5
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
Peter J. Bailey, Xu Zhou, Jing-Yu An, et al.
Function (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 12
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Raefa Abou Khouzam, Jean‐Maríe Lehn, Hemma Mayr, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1235-1235
Open Access | Times Cited: 11
Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results
Robert C. Chick, Andrew J. Gunderson, Shafia Rahman, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3967-3967
Open Access | Times Cited: 11
Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines
Nawal Amhis, Julie Carignan, Lee‐Hwa Tai
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200825-200825
Open Access | Times Cited: 4
Evaluation of the Anti-Cancer Efficacy of Cyclooxygenase Inhibition in Combination with Nutrient Starvation on Pancreatic Ductal Adenocarcinoma In Vitro
Ayşe Nur Çaldıran, Gizem Gürel, Başak Aru
Turkish Journal of Immunology (2025) Vol. 12, Iss. 3, pp. 114-124
Open Access
Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines
Anton Lahusen, Nora Minhöfer, Kim-André Lohse, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010579-e010579
Open Access
Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells
Philip Moresco, Jonathan P. Kastan, Jung‐In Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
aPD-L1-facilitated theranostic and tumor microenvironment remodeling of pancreatic cancer via docetaxel-loaded phase-transformation nanoparticles triggered by low-intensity pulsed ultrasound
Yi Tang, Qingling Shen, Peng Lin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
A novel signature predicts prognosis in pancreatic cancer based on tumor membrane-associated genes
Zhaowei Ding, Jun Wu, Yongqing Ye, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42791-e42791
Open Access
Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer
Enkui Zhang, Yongsu Ma, Zonghao Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Pancreatic Cancer: Pathogenesis and Clinical Studies
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Establishment and validation of an immune-related nomogram for the prognosis of pancreatic adenocarcinoma
Kan Wang, Yunkun Lu, Yanfei Cao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges
Zhichen Jiang, Xiaohao Zheng, Min Li, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1135-1169
Closed Access | Times Cited: 10
The preclinical gap in pancreatic cancer and radiotherapy
Mathias Tesson, Jennifer P. Morton
Disease Models & Mechanisms (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top